Nav: Home

IOF Medal of Achievement awarded to Professor Bess Dawson-Hughes

March 23, 2017

Florence, Italy - March 23, 2017 Bess Dawson-Hughes, Professor of Medicine and Director of the Bone Metabolism Laboratory of the Jean Mayer USDA Human Nutrition Research Center on Ageing at Tufts University, Boston USA, has been awarded the 2017 International Osteoporosis Foundation (IOF) Medal of Achievement.

Presented today at the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases, the IOF Medal of Achievement honours an individual researcher who has significantly advanced the field of osteoporosis through original and outstanding scientific contributions. The award underlines important aspects of IOF's mission - to increase understanding and awareness of osteoporosis and to promote medical innovation and improved care.

Professor Cyrus Cooper, Chair of the IOF Committee of Scientific Advisors, stated: "It is an honour to present this award to Professor Bess Dawson-Hughes, an internationally recognized leader in the bone field whose extensive body of research has led to greater understanding of the role of nutrition in age-related bone and muscle loss. I'd also like to pay tribute to Bess' longstanding commitment to international education and advocacy, which has contributed substantially to awareness of bone nutrition among health professionals and the public alike. Finally, she has served our Foundation for over a decade in the demanding role of General Secretary, contributing greatly to the growth and success of the Foundation over this time."

Professor Dawson-Hughes is acknowledged as a highly cited researcher who has published more 450 peer-reviewed journal articles, book chapters and reviews. She is the Founding Director of the Center for the Advancement of Science in Space (CASIS) that develops and oversees research on the International Space Station. She is on the Editorial Boards of Bone, Osteoporosis International and Calcified Tissue International; Associate Editor of the Journal of Bone and Mineral Research (1995-2003), Principle Investigator of the NIH Osteoporosis and Related Bone Disease National Resource Center, Washington, D.C (2000-2003), General Secretary of the International Osteoporosis Foundation, Advisory Council of NIAMS (Oct. 2000-2004), and Past President and Trustee of the National Osteoporosis Foundation (USA).

Among her many awards, Professor Dawson-Hughes has received the Bolton L. Corson Medal for Research from the Benjamin Franklin Institute (1995), IOF President's Award (2012), HNRCA Award for the most highly cited peer-reviewed Manuscript, NOF Lawrence G. Raisz Memorial Lecture Award (2014), Thomson Reuters Highly cited Scientist (2014) and the International Institute for Nutrition and Bone Health Research Award (2015).
-end-
World Congress on Osteoporosis, Osteoarthritis & Musculoskeletal Diseases (WCO-IOF-ESCEO Florence 2017):

Held jointly by IOF and ESCEO, the Congress takes place in Florence, Italy, from March 23-26, 2017. WCO-IOF-ESCEO is the world's largest annual forum for the presentation of clinical research and new advances in the prevention and management of bone, muscle and joint disorders, including sarcopenia and frailty. Congress abstracts will be published in Osteoporosis International, Volume 28, Supplement 1, March 2017. Congress abstracts will be published in Osteoporosis International, Volume 28, Supplement 1, March 2017. For complete information visit http://www.wco-iof-esceo.org #OsteoCongress

About IOF:

The International Osteoporosis Foundation (IOF) is the world's largest nongovernmental organization dedicated to the prevention, diagnosis and treatment of osteoporosis and related musculoskeletal diseases. IOF members, including committees of scientific researchers as well as 237 patient, medical and research societies in 99 locations, work together to make fracture prevention and healthy mobility a worldwide heath care priority. http://www.iofbonehealth.orghttp://www.facebook.com/@iofbonehealth

About ESCEO:

The European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) is a non-profit organization, dedicated to a close interaction between clinical scientists dealing with rheumatic disorders, pharmaceutical industry developing new compounds in this field, regulators responsible for the registration of such drugs and health policy makers, to integrate the management of osteoporosis and osteoarthritis within the comprehensive perspective of health resources utilization. The objective of ESCEO is to provide practitioners with the latest clinical and economic information, allowing them to organize their daily practice, in an evidence-based medicine perspective, with a cost-conscious perception. http://www.esceo.org

International Osteoporosis Foundation

Related Osteoporosis Articles:

New pharmaceutical target reverses osteoporosis in mice
Biomedical engineers at Duke University have discovered that an adenosine receptor called A2B can be pharmaceutically activated to reverse bone degradation caused by osteoporosis in mouse models of the disease.
A link between mitochondrial damage and osteoporosis
In healthy people, a tightly controlled process balances out the activity of osteoblasts, which build bone, and osteoclasts, which break it down.
Many stroke patients not screened for osteoporosis, despite known risks
Many stroke survivors have an increased risk of osteoporosis, falls or breaks when compared to healthy people.
Many postmenopausal women do not receive treatment for osteoporosis
The benefits of treating osteoporosis in postmenopausal women outweigh the perceived risks, according to a Clinical Practice Guideline issued today by the Endocrine Society.
A new 'atlas' of genetic influences on osteoporosis
A ground-breaking new study led by researchers from the Lady Davis Institute (LDI) at the Jewish General Hospital (JGH) has succeeded in compiling an atlas of genetic factors associated with estimated bone mineral density (BMD), one of the most clinically relevant factors in diagnosing osteoporosis.
New recommendations for the conduct of economic evaluations in osteoporosis
An expert working group has established recommendations for the design and conduct of economic evaluations in osteoporosis, as well as guidance for reporting these evaluations.
From receptor structure to new osteoporosis drugs
Researchers at the University of Zurich have determined the three-dimensional structure of a receptor that controls the release of calcium from bones.
How a Mediterranean diet could reduce osteoporosis
Eating a Mediterranean-type diet could reduce bone loss in people with osteoporosis -- according to new research from the University of East Anglia.
Osteoporosis drug may benefit heart health
The osteoporosis drug alendronate was linked with a reduced risk of cardiovascular death, heart attack, and stroke in a Journal of Bone and Mineral Research study of patients with hip fractures.
New treatment for osteoporosis provides better protection against fractures
A new treatment for osteoporosis provides major improvements in bone density and more effective protection against fractures than the current standard treatment.
More Osteoporosis News and Osteoporosis Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Reinvention
Change is hard, but it's also an opportunity to discover and reimagine what you thought you knew. From our economy, to music, to even ourselves–this hour TED speakers explore the power of reinvention. Guests include OK Go lead singer Damian Kulash Jr., former college gymnastics coach Valorie Kondos Field, Stockton Mayor Michael Tubbs, and entrepreneur Nick Hanauer.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at Radiolab.org/donate.